ICD-10 Logo
ICDxICD-10 Medical Coding
ICD-10 Logo
ICDxICD-10 Medical Coding
ICD 10 CodesDiagnoses
ICD 10 CodesDiagnoses
ICD-10 Logo
ICDxICD-10 Medical Coding

Comprehensive ICD-10-CM code reference with AI-powered search capabilities.

© 2025 ICD Code Compass. All rights reserved.

Browse

  • All Chapters
  • All Categories
  • Diagnoses

Tools

  • AI Code Search
ICD-10-CM codes are maintained by the CDC and CMS. This tool is for reference purposes only.
v1.0.0
ICD-10 Guide
ICD-10 CodesChapter 2: NeoplasmsD14

D14

Billable

Benign neoplasm of middle ear and respiratory system

Chapter 2:Neoplasms

BILLABLE STATUSYes
IMPLEMENTATION DATEOctober 1, 2015
LAST UPDATED09/05/2025

Code Description

ICD-10 D14 is a billable code used to indicate a diagnosis of benign neoplasm of middle ear and respiratory system.

Key Diagnostic Point:

Benign neoplasms of the middle ear and respiratory system encompass a variety of non-cancerous growths that can occur in these anatomical regions. These neoplasms may arise from epithelial, mesenchymal, or neurogenic tissues and can manifest as polyps, adenomas, or other types of tumors. Clinically, they may present with symptoms such as hearing loss, nasal obstruction, or respiratory distress, depending on their location and size. While benign, these neoplasms can lead to complications if they obstruct airways or cause significant anatomical distortion. Surveillance is often recommended to monitor for any changes in size or symptoms, as some benign neoplasms can exhibit atypical features that warrant further investigation. Although the malignant potential of these neoplasms is generally low, certain types may have a risk of transformation, necessitating careful follow-up and management. Accurate diagnosis typically involves imaging studies and histopathological examination, which are crucial for determining the appropriate treatment approach.

Code Complexity Analysis

Complexity Rating: Medium

Medium Complexity

Complexity Factors

  • Variety of benign neoplasm types that can be coded under this category
  • Need for precise documentation to differentiate between benign and malignant conditions
  • Potential for overlapping symptoms with other respiratory or ear conditions
  • Variability in clinical presentation and management strategies

Audit Risk Factors

  • Inadequate documentation of the neoplasm's characteristics
  • Failure to document the clinical rationale for surveillance
  • Misclassification of benign neoplasms as malignant
  • Lack of follow-up documentation indicating monitoring of the neoplasm

Specialty Focus

Medical Specialties

Otolaryngology

Documentation Requirements

Detailed descriptions of the neoplasm's location, size, and symptoms, along with imaging and biopsy results.

Common Clinical Scenarios

Patients presenting with hearing loss or nasal obstruction due to benign tumors.

Billing Considerations

Ensure clear documentation of the benign nature of the neoplasm to avoid misclassification.

Pulmonology

Documentation Requirements

Comprehensive pulmonary function tests and imaging studies to assess the impact of the neoplasm on respiratory function.

Common Clinical Scenarios

Patients with respiratory symptoms attributed to benign lung neoplasms.

Billing Considerations

Document any changes in symptoms or size of the neoplasm during follow-up visits.

Coding Guidelines

Inclusion Criteria

Use D14 When
  • According to ICD
  • 10 guidelines, D14 is used for benign neoplasms specifically located in the middle ear and respiratory system
  • Accurate coding requires documentation of the neoplasm's characteristics and clinical significance

Exclusion Criteria

Do NOT use D14 When
  • Exclusion criteria include malignant neoplasms and conditions not classified as neoplasms

Related CPT Codes

31255CPT Code

Nasal endoscopy with biopsy

Clinical Scenario

Used when a benign nasal neoplasm is suspected.

Documentation Requirements

Document the indication for the procedure and findings.

Specialty Considerations

Otolaryngologists should ensure thorough documentation of the procedure and findings.

ICD-10 Impact

Diagnostic & Documentation Impact

Enhanced Specificity

ICD-10 Improvements

The transition to ICD-10 has allowed for more specific coding of benign neoplasms, improving the accuracy of data collection and reimbursement processes. The granularity of ICD-10 codes helps in better tracking of these conditions and their management.

ICD-9 vs ICD-10

The transition to ICD-10 has allowed for more specific coding of benign neoplasms, improving the accuracy of data collection and reimbursement processes. The granularity of ICD-10 codes helps in better tracking of these conditions and their management.

Reimbursement & Billing Impact

reimbursement processes. The granularity of ICD-10 codes helps in better tracking of these conditions and their management.

Resources

Clinical References

  • •
    ICD-10-CM Official Guidelines for Coding and Reporting

Coding & Billing References

  • •
    ICD-10-CM Official Guidelines for Coding and Reporting

Frequently Asked Questions

What is the difference between benign and malignant neoplasms?

Benign neoplasms are non-cancerous growths that do not invade surrounding tissues or metastasize, while malignant neoplasms are cancerous and can spread to other parts of the body.